Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DEC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,814
Award facts
- Contract value 100% obligated
- $35,813.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a firm fixed price ceiling value of $35,813.55 and completion date of January 2, 2026. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems, supplying a comprehensive range of medications and medical supplies across multiple therapeutic domains.
This delivery order falls within AmerisourceBergen's established role as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience fulfilling defense health procurement requirements for specialty medications, brand-name and generic drugs, and medical commodities. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to support military healthcare programs globally, including service to the Defense Health Agency and other government healthcare systems. As part of the broader Pharmaceutical Prime Vendor Global Program, AmerisourceBergen maintains significant pharmaceutical distribution capacity to meet federal medical supply needs across multiple therapeutic categories, including endocrinology treatments such as Jardiance.
Quick answers
Who was awarded contract SPE2DR26F6DEC?
SPE2DR26F6DEC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F6DEC worth?
The government has obligated $35,814 on SPE2DR26F6DEC.
Is contract SPE2DR26F6DEC an order under another contract?
Yes. SPE2DR26F6DEC is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DEC competed?
The extent of competition for SPE2DR26F6DEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award